ERCC6L2 and myelodysplastic syndrome: Likewise, ERCC6L2, a gene mutated in MDS and leukaemia that is associated with bone marrow failure, was identified as a new NHEJ factor recruited to chromatin after IR promoting DNA end-joining independent of the 53BP1-RIF1-shieldin pathway [235].